Global Gastrointestinal Biopsy Forcep Market Size By Type (Single-use Biopsy Forceps, Reusable Biopsy Forceps), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

lobal Gastrointestinal Biopsy Forcep Market Report Description

The Global Gastrointestinal Biopsy Forcep Market was valued at USD 845 million in 2023 and is projected to reach USD 1.45 billion by 2031, growing at a CAGR of 6.9% during the forecast period from 2023 to 2031. The growth is primarily driven by the rising prevalence of gastrointestinal (GI) disorders, increasing demand for early cancer detection, and the adoption of minimally invasive endoscopic procedures. Biopsy forceps are essential tools used in gastroenterology to collect tissue samples for diagnostic analysis, significantly contributing to improved patient outcomes through timely diagnosis.

Drivers

1. Rising Prevalence of Gastrointestinal Diseases

The global incidence of conditions such as colorectal cancer, Crohn’s disease, and gastrointestinal bleeding has significantly increased, resulting in a higher demand for diagnostic endoscopy procedures. This directly fuels the need for high-quality biopsy forceps.

2. Advancements in Endoscopic Technologies

Technological innovations such as single-use biopsy forceps, coated forceps for improved precision, and integration with HD endoscopes are enhancing diagnostic accuracy, driving market expansion.

3. Growing Geriatric Population

The aging population is more susceptible to GI-related diseases, increasing the demand for diagnostic tools like biopsy forceps, particularly in developed regions.

Restraints

1. High Cost of Endoscopic Equipment

While biopsy forceps themselves are relatively low-cost, the complete setup for endoscopic procedures can be expensive, limiting adoption in low-income regions.

2. Risk of Infection and Complications

Reusable biopsy forceps carry a risk of cross-contamination if not properly sterilized. This has led to regulatory scrutiny, slightly dampening market growth in some regions.

Opportunity

1. Surge in Demand for Single-Use Devices

Increasing awareness about infection control and regulatory pressure is shifting the industry towards disposable biopsy forceps, presenting substantial growth opportunities.

2. Expansion of Endoscopy Centers in Emerging Markets

Countries in Asia-Pacific and Latin America are witnessing a boom in healthcare infrastructure development, including GI specialty clinics, creating new revenue streams for market players.

Market by System Type Insights

Based on system type, the Single-Use Biopsy Forceps segment accounted for the largest market share in 2023. Their growing popularity is attributed to reduced cross-contamination risk, ease of use, and lower sterilization costs. Meanwhile, Reusable Biopsy Forceps continue to hold relevance in cost-sensitive environments, but their growth is comparatively slower due to stricter hygiene regulations.

Market by End-use Insights

The Hospitals segment emerged as the dominant end-use sector in 2023, driven by a higher volume of GI procedures and better infrastructure. The Ambulatory Surgical Centers (ASCs) segment is expected to witness faster growth, supported by the global shift towards outpatient care and same-day procedures.

Market by Regional Insights

North America held the largest market share in 2023, supported by advanced healthcare infrastructure, high awareness levels, and widespread screening programs for colorectal cancer. However, Asia-Pacific is projected to witness the fastest growth during the forecast period due to increasing healthcare investments, a rising elderly population, and growing access to endoscopy services in countries like India and China.

Competitive Scenario

Key players in the global gastrointestinal biopsy forcep market include Boston Scientific Corporation, Olympus Corporation, Medtronic plc, CONMED Corporation, Steris plc, Cook Medical, Pentax Medical, and MTW Endoskopie. Companies are investing in R&D, product launches, and strategic partnerships to expand their portfolios and cater to the growing demand for safer and more effective biopsy solutions.

Scope of Work – Global Gastrointestinal Biopsy Forcep Market

Report Metric Details

Market Size (2023) USD 845 million

Projected Market Size (2031) USD 1.45 billion

CAGR (2023–2031) 6.9%

Market Segments By System Type (Single-use, Reusable), By End-use (Hospitals, ASCs, Specialty Clinics)

Growth Drivers Rising GI disease prevalence, aging population, technological advancements

Opportunities Shift to disposable forceps, emerging market expansion

Key Market Developments

2023: Olympus Corporation launched an upgraded line of single-use biopsy forceps with enhanced jaw design for better tissue sampling.